Search

Your search keyword '"Aplastic Anemia"' showing total 15,737 results

Search Constraints

Start Over You searched for: Descriptor "Aplastic Anemia" Remove constraint Descriptor: "Aplastic Anemia"
15,737 results on '"Aplastic Anemia"'

Search Results

1. The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates.

2. Risk factors for a failed first attempt at pediatric subclavian central venous catheters and the role of single-attempt placement in reducing catheter-related morbidity: a prospective observational study.

3. Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report.

4. Up-Regulated Expression of Thioredoxin-Interacting Protein (TXNIP) in Mesenchymal Stem Cells Associated with Severe Aplastic Anemia in Children.

5. Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.

6. PDGF-BB Deficiency in the Blood Serum from Aplastic Anemia Patients Affects Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells.

7. Annexin A1: a key regulator of T cell function and bone marrow adiposity in aplastic anaemia.

8. Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia.

9. Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance database.

10. Maternal and Fetal Outcomes of Aplastic Anemia During Pregnancy and Delivery: Systematic Review and Meta‐Analysis.

11. Haematopoietic regeneration by HLA‐A*0206‐deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment.

12. Extent of iron induced organ damage in patients with hematological disorders.

13. The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia.

14. Ten years of detecting Neoehrlichia mikurensis infections in Sweden: demographic, clinical and inflammatory parameters.

15. Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia.

16. Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia.

17. γδ and αβ T‐cell large granular lymphocytic leukaemia have similar characteristics and outcomes.

18. PANSITOPENIA: CHALLENGES OF APPROACH AND CASE HANDLING IN PERIPHERAL HOSPITALS.

19. Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia.

20. Genomic insights into inherited bone marrow failure syndromes in a Korean population.

21. Un caso de anemia aplásica asociado a la terapia con letrozol en una paciente con cáncer de mama: Un desafío en el manejo oncológico.

22. Recurrent acute myocardial and renal infarction with aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome: a case report.

23. Establishment of a Diamond‐Blackfan anemia like model in zebrafish.

24. Integrating network pharmacology and experimental validation to explore the mitophagy‐associated pharmacological mechanism of modified Shisiwei Jianzhong decoction against aplastic anemia.

25. 当归多糖调节骨髓造血微环境治疗再生障碍性贫血的机制.

26. Influence of baseline telomere length on the results of immunosuppressive therapy in aplastic anemia patients

27. Dynamics of T cell subpopulation in patients with aplastic anemia during immunosuppressive therapy

28. Platelet indices as a predictor in patients with aplastic anemia and immune thrombocytopenic purpura: a retrospective case–control study

29. Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia

30. Trilineage hematopoietic recovery with romiplostim in a child with down syndrome and aplastic anemia: A case report and review of literature

31. Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – A case report

32. Hypocalcemia and Hypoparathyroidism Associated With Critical Illness and Aplastic Anemia

33. Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period.

34. Platelet indices as a predictor in patients with aplastic anemia and immune thrombocytopenic purpura: a retrospective case–control study.

35. MAIT Cells in the Bone Marrow of Patients with Aplastic Anemia.

36. Comprehensive mapping of immune perturbations associated with aplastic anemia.

37. Cyclosporine-induced alopecia: a case report, FDA adverse event reporting system analysis and literature assessment.

38. Ovarian tissue cryopreservation after graft failure of allogeneic hematopoietic stem cell transplantation: first report and literature review.

39. Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database.

40. Atypical Manifestation of Oral Candidiasis in Patient with Aplastic Anemia.

41. Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.

42. Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.

43. Etiology of pancytopenia with reference to bone marrow biopsy in a tertiary care hospital: A hospital-based study.

44. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

45. Potential role of B- and NK-cells in the pathogenesis of pediatric aplastic anemia through deep phenotyping.

46. Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital.

47. Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia.

48. Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights.

49. Global microRNA profiling of bone marrow-MSC derived extracellular vesicles identifies miRNAs associated with hematopoietic dysfunction in aplastic anemia.

50. Retrospective identification of the first cord blood–transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background.

Catalog

Books, media, physical & digital resources